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Abstract.  13-Tubulin is encoded in the genomes of 
higher animals by a  small multigene family comprising 
approximately seven functional genes.  These genes 
produce a  family of closely related,  but distinct poly- 
peptide isotypes that are distinguished principally by 
sequences within the ,x,15 carboxy-terminal amino acid 
residues.  By immunizing  rabbits with chemically syn- 
thesized peptides corresponding to these variable do- 
main  sequences,  we have now prepared polyclonal 
antibodies specific for each of six distinct isotypes. 
Specificity of each antiserum has been demonstrated 
unambiguously by antibody binding to bacterially pro- 
duced, cloned proteins representing  each isotype and 
by the inhibition of such binding by preincubation of 
each antiserum only with the immunizing peptide and 
not with heterologous peptides.  Protein blotting of 
known amounts of cloned, isotypically pure polypep- 
tides has permitted accurate quantitative measurement 
of the amount of each 13-tubulin isotype present in the 
soluble and polymer forms in various cells, but has 
not revealed a bias for preferential assembly of any 
isotype. Localization of each isotype in three different 
cell types using indirect immunofluorescence has 
demonstrated that in vivo each class of microtubules 
distinguishable by light microscopy is assembled as 
copolymers of all isotypes expressed in a  single cell. 
M 
ICROTUBULES are  ubiquitous  structural  compo- 
nents of eukaryotic cells. Composed principally  of 
heterodimeric subunits of one a-and one 13-tubulin 
polypeptide, microtubules serve several divergent functional 
roles within cells. They are the primary components through 
which accurate chromosome segregation  is achieved during 
meiosis and mitosis, and they serve as major structural  com- 
ponents for ciliary- and flagellar-dependent  cell motility, for 
establishment  of the asymmetric morphology of neurons, 
and as a substrate for the transport of vesicles and organelles 
within the cytoplasm (Hayden and Allen,  1984; Vale et al., 
1985). In addition,  together with actin filaments  and inter- 
mediate filaments,  microtubules of the cytoskeleton play a 
major role in establishing  and maintaining  the dynamic and 
spatial  organization  of the  cytoplasm  (e.g.,  Heuser  and 
Kirschner,  1980; Kirschner and Mitchison,  1986). 
This heterogeneity  of function is paralleled by a diversity 
in biochemical and molecular properties of microtubules. 
Microtubules within  single  cells show differences  in their 
stability  (Brinkley  and  Cartwright,  1975; Schulze  and 
Kirschner,  1987), assembly (Schulze  and  Kirschner,  1987; 
Murphy and Wallis,  1985), and patterns of posttranslational 
modification (Gundersen et al., 1984; L'Hernault and Rosen- 
baum,  1985; Piperno et al.,  1985). Furthermore,  microtu- 
bules in different  cells show dramatic  differences  in  their 
complement of microtubule associated proteins  (Bulinski 
and Borisy,  1980; Binder et al.,  1985; Bloom et al.,  1984; 
Huber and Matus,  1984; Parysek et al., 1984). Nonetheless, 
the relationship  of microtubule heterogeneity  to microtubule 
function remains  obscure, as do the mechanisms by which 
cells regulate  the molecular properties of microtubules. 
The possible role of the tubulin subunit itself as a modula- 
tor that can specify microtubule function  remains unsettled 
(see Cleveland,  1987 for recent review).  Our initial demon- 
stration that eukaryotic genomes contain multigene  families 
for ~t- and 13-tubulin (Cleveland et al.,  1980) rekindled  ear- 
lier speculations  that such organisms possessed functionally 
differentiated tubulins that could be used to construct differ- 
ent  kinds  of  microtubules  (Fulton  and  Simpson,  1976; 
Stephens,  1975). It is now clear (principally  from our efforts 
and those of Cowan and collaborators [Wang et al.,  1986; 
Villasante et al., 1986]) that in vertebrates both a- and ~-tu- 
bulin are encoded by approximately  six or seven functional 
genes.  For the I]-tubulins, our studies  (Sullivan and Cleve- 
land,  1984; Sullivan et al., 1986a, b; Sullivan and Cleveland, 
1986) and those of Cowan's group (Hall et al.,  1983; Lewis 
et ai.,  1985a,b;  Wang et al.,  1986) have  established  that 
these multiple  genes encode polypeptides that differ in se- 
quence and in patterns  of expression.  Within  an otherwise 
conserved polypeptide framework, the distribution  of amino 
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to domains at the extreme carboxy terminus,  and to a lesser 
extent,  near the amino terminus  (Sullivan  and Cleveland, 
1986). Further,  sequences of at least four of these carboxy- 
terminal  region  domains  define  evolutionarily  conserved 
13-tubulin polypeptide  isotypes  (Sullivan  and  Cleveland, 
1986). 
To investigate further the functional properties of 13-tubu- 
lin isotypes, we have now exploited  the divergent  carboxy- 
terminal domain sequences to chemically synthesize the pep- 
tides corresponding to each of the four evolutionarily  con- 
served isotypic classes.  Peptides for two additional chicken 
13-tubulin polypeptide sequences (not known to be found in 
other organisms)  have also been prepared.  We have used 
these peptides as immunogens  to generate  polyclonal  anti- 
bodies to each t3-tubulin isotype. The specificity of the an- 
tisera has been extensively  characterized  by using  cloned 
DNA sequences to direct expression  in bacteria of hybrid 
proteins containing  the carboxy terminus  of each of the six 
13-tubulin isotypes. The isotype-specific antibodies,  in con- 
junction with the corresponding cloned proteins,  have been 
used to develop an accurate and quantitative  assay for the 
13-tubulin isotypic composition in the soluble and polymeric 
forms in various cell lines. Finally, indirect immunofluores- 
cence analysis of isotypic composition in vivo has demon- 
strated that all microtubule classes distinguishable  by light 
microscopy are assembled as copolymers of all  available 
isotypes. 
Materials and Methods 
Peptide Synthesis and Coupling 
Synthetic peptides were chemically synthesized using a peptide synthesizer 
(Applied Biosciences,  Inc., Foster  City, CA).  After purification  by high- 
performance liquid chromatography  (on a C- 18 column), sequences of each 
peptide  were verified by analysis of amino acid composition and/or direct 
sequence analysis  using an automated  Applied Biosciences protein se- 
quencer.  Peptides  (6  ￿  10  -7 tool in phosphate-buffered  saline [PBS],  pH 
7.4) were coupled to the carrier protein keyhole limpet hemocyanin (KLH, 
Calbiochem-Behring Corp., San Diego,  CA) (8  ￿  10  -9 mol in PBS) by 
cross-linking with gluteraldehyde  (Electron Microscopy  Sciences,  Fort 
Washington,  PAL The peptides and KLH were mixed on ice and 10  -~ mol 
of gluteraldehyde was added and then rotated for 20 h at room temperature. 
The complex was dialyzed  against two changes of Tris-buffered  saline (20 
mM Tris,  pH 7.4,  130 mM NaCI)  for 16 h, aliquoted,  and stored  frozen 
(-20~ 
Immunization of  Rabbits with Peptides 
Cross-linked peptide/KLH (6 ￿  10  -s mol) and free peptide (4 x  l0 s mol 
in PBS, pH 7.4) were sonicated into an emulsion with complete Fretmd's 
adjuvant. Each emulsion was injected subcutaneously  into a New Zealand 
white rabbit (in four spots along the back). The inoculation was repeated 
after 20 d and again on day 35, this time with incomplete Freund's adjuvant. 
Rabbits were ear bled on day 48. The blood was allowed to clot, and the 
serum was collected  and stored at -200C. 
Preparation of  Affinity Columns Containing 
Peptide Covalently Linked to Sepharose 
3.5 g of wet, cyanogen bromide (CNBr)-activnted Sepharose 4B (Pharmaeia 
Fine Chemicals, Piscataway, NJ) and 20 mg ofpeptide in 0.5 M NaC1, 0.1 M 
NaI-ICO3 (pH 8.8) were mixed gently overnight at 4~  The Sepharose was 
pelleted by low-speed  centrifugation and remaining unreacted sites were 
1. Abbreviations  used  in  this paper:  KLH,  keyhole  limpet hemocyanin; 
CEE chicken embryo fibroblasts. 
quenched with 1 M triethanolamine, pH 8. The Sepharose  was washed se- 
quentially with acetate  buffer  (1 M NaC1, 0.1 M  sodium acetate,  pH 4), 
borate buffer (1 M NaC1, 0.1 M sodium borate, pH 8), and phosphate buffer 
(0.3 M NaCI,  10 mM NaH2PO4, pH 6.9) prior to storage at 4~ 
Affinity Purification of  Antibodies 
Immune serum and peptide-aflinity  columns ware gently mixed overnight 
at 200C to allow antibody binding  to the immobilized peptide.  Unbound an- 
tibodies were collected  and the column was washed successively  with P 
buffer (0.3 M NaC1,  10 mM NaHPO4,  pH 6.9), with P buffer containing 
0.2% Triton X-100, and with P buffer. The bound antibody was eluted with 
two column volumes of citrate buffer (0.3 M NaC1, 0.1 M sodium citrate, 
pH 2.2), and neutralized  immediately  with Tris-HC1, pH 9.1. The aflinity- 
purified antibody was brought to 5 mg/ml bovine serum albumin (BSA) and 
stored at -80~ 
Construction of  Expression Plasmids Containing 
the Carboxy-Terminal  Sequences of  Each of  Six 
~-Tubulin Isotypes Fused to the Bacterial Gene trpE 
For each of six ~tubuiin isotypes, a plasmid was constructed which carried 
a chimeric gene that directed the synthesis of a fusion protein in bacteria. 
In each instance the resultant fusion protein contained an amino-terminal 
32 kD of the bacterial protein trpE linked to amino acid regidues  from 
13-tubulin beginning at codon 345 through to the earboxy terminus. To do 
this, we exploited the property that essentially all vertebrate 13-tubulins  con- 
tain a conserved Barn HI site within codon 344. The following l~-tubulin 
fragments were isolated and inserted in the proper orientation into the 
unique Barn HI site of the trpE gene in pATH 1 (kindly provided by Dr. 
1". J. Keerner,  Duke University): 
Type I. A 0.5-kb Barn HI fragment from human gene hi31. (This was ob- 
tained from a eDNA clone [Sullivan and Cleveland, unpublished results] 
for the human hill gene [originally  named M40-Lee et al.,  1983].) 
Type II. Because the carboxy-terminal  sequence of this isotype differed 
in two positions between the rat and mouse or chicken and porcine se- 
quences, isotype plasmids were engineered to produce both the rat/mouse 
and chicken/porcine variants.  For the rat/mouse variant: the 0.75-kb Bam 
HI fragment of mouse genr ml32 (Sullivan and Cleveland, 1986) was used. 
For the chicken/porcine variant, the 1.8-kb Barn HI fragment of gene el32 
(Lopata et al.,  1983) was used. 
Type IlL Because the chicken and human type III carboxy-terminal  se- 
quences differ in two residue positions, two plasmids were constructed. FOr 
human type III, a 0.5-kb Barn HI fragment from a eDNA clone of hiM (Sul- 
livan and Cleveland, 1986) was used.  FOr chicken type IR, a 2.5-kb Barn 
HI fragment from gene elm (Sullivan and Cleveland, 1984) was used. 
Mammalian I)~pe IV (m-IV). A 0.5-kb Barn HI fragment from a eDNA 
clone (Sullivan and Cleveland, unpublished  results) derived from the human 
1~2 gene (Lewis et al.,  1985a) was used. 
Chicken ~  IV (c-IV). The 4.4-kb Barn HI fragment from gene c1~3 
(Lopata et al., 1983) was used.  (This gene encodes the dominant 13-tubulin 
in chicken testis.) 
Chicken ~pe V(c-V). The 4.8-kb Barn HI fragment from gene el35 (Sul- 
livan et al.,  1986a) was used.  (The cl35 gene encodes a chicken 13-tubulin 
expressed  in many tissues.) 
Induction of  Cloned Fusion Proteins 
Plasmids carrying each 13-tubuiin carboxy terminus linked in the correct 
orientation to the trpE gene were transformed into Escherichia coli strain 
CAG456 (Snyder et al.,  1987). Expression of the fusion protein, which is 
controlled by the trpE promoter, was induced with 27 mM (5 p.g/ml) indole 
acrylic acid (IAA, Sigma Chemical Co., St. Louis,  MO). To do this, bac- 
terial clones harboring each plasmid were grown overnight at 300C in M9 
minimal media containing 20 gg/ml tryptophane (Maniatis et al., 1982). To 
induce the protein, the bacterial culture was diluted (1:10) into M9 media 
without tryptophane and grown 2 h at 30~  with vigorous aeration. The in- 
ducer (solubilized in ethanol) was added to 5 gg/ml and the cultures were 
allowed to grow 2 h at 30~  Extracts containing the fusion proteins were 
prepared by pelleting the bacteria by centrifugation, washing the cell pellets 
once with 10 mM Tris-HCI (pH 8), and resuspension in Laemmli gel sample 
buffer (Laemmli, 1970). After boiling for 5 min, bacterial DNA was pelleted 
by centrifugation (5 min at 12,000 g) and the supernatant containing solubi- 
lized proteins was recovered. Samplers were electrophoresed  immediately or 
stored  at -200C. 
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Polyacrylamide gels for analysis of protein samples were run as described 
by  Laemmli  (1970).  Proteins  were  transferred to  nitrocellulose  (BA83, 
Schleicher & Schuell, Inc., Keene, NH) in one-half strength Laemmli gel 
running buffer (Laemmli, 1970) plus 20% methanol. Typically,  transfer was 
for 4 h at 50 V. Filters containing transferred samples were stained with Pon- 
ceau S (0.2% Ponceau S in 3% trichloroacetic acid) to identify positions 
of molecular  weight  standards.  Nonspecific protein-binding sites  were 
blocked by incubation in PTX-BSA (0.2%  Triton X-100, 0.15 M  NaC1, 
10 mM NaH2PO4,  pH 7.5,  1 mM EGTA, 4% BSA) for 10 min. FOr im- 
munologic detection of proteins, primary antibody in PTX-BSA was then 
added and allowed to react overnight at room temperature. In some cases, 
chemically synthesized peptides were preincubated with this primary anti- 
body to test the specificity of the antibody binding. Unbound primary anti- 
body was removed and the filters were washed five times (3 min each wash) 
in GB (0.5% Triton X-100, 50 mM triethanolamine, pH 7.4,  0.I M NaC1, 
0.1 mM EDTA, 0.1% SDS). 12~I-labeled  protein A in PTX-BSA was added 
and incubated for 1 h at room temperature, followed by five washes (3 min 
each wash) in GB to remove unbound protein A. Binding was detected by 
autoradiography using Dupont Lightning Plus intensifying screens (DuPont 
Co., Wilmington, DE) and Kodak XAR film (Eastman Kodak Co., Roches- 
ter, NY). 
Preparation of Cell Extracts Containing Soluble, 
Polymeric, or Total Tubulin 
To prepare extracts of total cell proteins, a 100-ram dish of "~50% confluent 
cells was washed four times with 5 mi of PBS before lysis with 200 p,l of 
50 mM Tris, pH 6.8, 0.1% SDS. The lysate was scraped into a microfuge 
tube and boiled for 5 min, and the DNA was removed by centrifugation (3 
rain, 12,000 g). Protein concentration was determined by the bicinchoninic 
acid protocol (Smith et al.,  1985). 
For preparation of soluble and polymeric fractions of cell tubulin, cells 
were washed twice with PBS (at 37~  and then twice with microtubule 
stabilizing buffer (0.1 M Pipes, pH 6.9,  1 mM EGTA, 4% polyethylene gly- 
col 8000).  Soluble proteins were extracted by lysis in  1 ml of stabilizing 
buffer containing 0.5% Triton X-100. Extraction was continued for 5 min 
at 37~  The solution was removed, any insoluble material in the soluble 
fraction was pelleted by centrifugation (12,000 g for 1 rain), and the soluble 
fraction was made 1X Laemmli gel sample buffer by addition of 280 ltl of 
a 5X stock and 120 ~tl of 2-mercaptoethanol. The remaining cytoskeletal 
fraction (including the pellet from centrifugation of the soluble fraction) was 
solubilized in 1.4 ml of Laemmli gel sample buffer. After boiling for 3 min, 
DNA was removed from the polymeric fraction by centrifugation (12,000 g). 
Both fractions were concentrated by precipitation with 9 vol of cold metha- 
nol, after addition of tRNA carrier to  100 I~g/ml. After 1 hr at  -20~ 
precipitated protein was recovered by centrifugation at 9,000 g for 20 min 
at 4~  Pellets were dried and resuspended in 200 Ixl of Laemmli gel sample 
buffer.  Samples were boiled and electrophoresed immediately or stored at 
-20~ 
Quantitation of  Amounts of  Each fl-Tubulin Isotype 
In order to use protein blotting to determine accurately the amount of each 
13-tubulin isotype present in various samples, the samples were electropho- 
resed on a series of parallel gels. On each gel, serial'dilutions of a bacterial 
extract containing one of the cloned fusion protein isotypes were loaded ad- 
jacent to lanes of samples to be quantified.  The  gels were blotted and 
processed with the primary antibody corresponding to the fusion protein di- 
lutions present on each blot. Autoradiography of  the fusion protein dilutions 
provided internal standards for densitometric quantitation of the signals of 
each sample. 
The amount of cloned fusion protein contained in a specific iysnte dilu- 
tion was determined by coelectrophoresis of a known volume of fusion pro- 
tein extract with serial dilutions of known amounts of BSA. From densito- 
metric comparison of the intensity of the Coomassie Blue staining of the 
fusion protein and the BSA standards, the amount of fusion protein was de- 
termined.  By knowing the molecular weight of the  fusion protein,  the 
molar amount of 13-tubulin carboxyterminus in a specified volume of lysate 
was then calculated. 
lmmunofluorescence 
Cells were grown overnight on glass coverslips. Coverslips were washed for 
15 s at 37~  with stabilization buffer (0.1 M Pipes, pH 6.9,  1 mM EGTA, 
and 4M glycerol) and then incubated for I min at 37~  in stabilization buffer 
containing 0.5% Triton X-100. Coverslips were then rinsed in stabilization 
buffer (15 s at 37~  and plunged into methanol at -20~  for 5 rain. The 
coverslips were rehydrated in PBS and stained with the isotype-specific  anti- 
body (1:20 to 1:100 in PBS supplemented with 0.5% BSA) for 1 h at room 
temperature. They were then rinsed with PBS and a  fluorescein-labeled 
anti-rabbit IgG antibody (Cooper Biomedical) was applied for 45 min at 
room temperature. The coverslips were rinsed with PBS and mounted in 
Aqua-mount (Lerner Laboratories, New Haven, CT). The cells were exam- 
ined on an Olympus BH-2 microscope with epifluorescent optics and pho- 
tographed on Kodak Tri-X  film developed in Diafine. 
Results 
Synthesis of  Peptides Corresponding to the 
Extreme Carboxy Termini of  Six ~-Tubulin Isotypes 
From comparison of known vertebrate [I-tubulin sequences, 
we have previously identified four evolutionarily conserved 
classes  of 13-tubulin polypeptides  (Sullivan and Cleveland, 
1986).  These  classes  are  distinguished  primarily  through 
their divergent carboxy-terminal sequences and, so far as is 
known,  each  isotypic  class  is expressed  in  analogous de- 
velopmental programs in each species investigated.  To pre- 
pare polyclonal antibodies that would bind uniquely to in- 
dividual  isotypic  classes,  we  chemically  synthesized  the 
carboxy-terminal peptides for each of the four classes.  Fig. 
1 displays the carboxy-terminal sequences of each of the vari- 
ous vertebrate [~-tubulins and the boxed regions correspond 
to the actual peptides that were produced. Note that for both 
type II and type III isoforms, although the terminal regions 
are clearly homologous in each of the species for which the 
isotype has been identified, there are minor amino acid dif- 
ferences between the members of the class. For example, for 
type II the chicken and pig sequences have the dipeptide GE 
whereas the mouse and rat isotypes have EG. Similarly, the 
type III human and chicken variants differ in two of the final 
20 positions. As shown in the figure, we chose to synthesize 
the rat/mouse type II and human type III peptide. 
To prepare as complete a set of isotype-specific I~-tubulin 
antibodies  as possible,  we also synthesized  two additional 
peptides corresponding to chicken isoforms cfl3 and cfl5. Al- 
though we had tentatively proposed that cl33 represented the 
dominant testis 13-tubulin isotype (Sullivan and Cleveland, 
1986),  in view of the high homology of cl33 to the type IV 
sequence, coupled with the demonstration from Cowan's lab- 
oratory (Wang et al.,  1986) that the type IVB mouse gene 
(mfi4' in our nomenclature  [Sullivan and Cleveland,  1986] 
and ml33 in Cowan's) is the dominant mouse testis 13 tubulin, 
we now conclude that cl33 represents the chicken type IVB 
gene.  For cl35,  inspection  of the available vertebrate  13-tu- 
bulin sequences reveals that no cognate gene in other species 
has yet been reported for this isotype (even though c[15 is ex- 
pressed in many chicken tissues [Sullivan et al.,  1986]). 
To raise polyclonal antibodies against these six carboxy- 
terminal peptides, each peptide was cross-linked with glutar- 
aldehyde to the carrier protein KLH and, after emulsifying 
with adjuvant, injected into rabbits (see Materials and Meth- 
ods for details). 
Determination of the Specificities of the 
Antipeptide Antibodies 
To assess unambiguously whether antibodies that recognized 
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__h l     EOFIOE A E A I 
rat  rbt.3  E  E  E  E  D  F  G  E  E  A  E  E  E  A 
mouse  m~5  E  E  E  E  D  F  G  E  E  A  E  E  E  A 
CLASS  II  I$~J[II~g  -  ~IOR  BRAIN  ISOTYPE 
chick  o~1/r  D  E  O  G  E  F  E  E  E  G  E  E  D  E  A 
pig  D  E  Q  G  E  F  E  E  E  G  E  E  B  E  A 
~at  ~bt.1  D  E  Q  G  E  FIE  E  E  E  G  E  D  E  A[ 
mouse  mp2  D  E  0  G  E  F  E  E  E  E  G  E  D  E 
CLASS  III  I8OTYPIg  -  MINOR  BRAIN  ISOTYPE 
chick  c~4  E  E  E  G  E  M Y  E 
human  hp4  E  E  EIG  E  M Y  E 
CLASS  IV  I~IIYE 
DD  E  EES  E-QGAK 
D  D  E  E  E  S  E'S  Q  G  P  K[ 
va~iant  IV  A  -  BRAIN  SPECIFIC 
rat  rbt.2  E  E  G  E  F IE  E  E  A  E  E  E  V  A 
human  51~  E  E  G  E  FIE  E  E  A  E  E  E  V  A 
mouse  m~4  E  E  G  E  F  E  E  E  A  E  E  E  V  A 
variant  IV  B  -  DOMINANT  TESTIS 
f 
h~2  E  E  E  G  EF tEE  E  A  E  E  E  V  A  human 
mouse  m~4'(m~3)  E  E  E  G  E  FIE  E  E  A  E  E  E,,V,  A 
chick  c~3  E  E  E  G  E  F t E  E  E  A  E  E  E  A  E 
CLASS  oV  ISOTrPI~  -  UBIQUITOUS,  EXCEPT  BRAIN 
chick  c~5  N  D  O  E  E  A  F[E  D  D  E  E  E  I  N'""E  I 
Figure 1. Carboxy termini of known vertebrate i~-tubulin polypep- 
tides. The one letter amino acid code has been utilized to show the 
extreme  carboxyterminal  sequences  of known vertebrate  13-tu- 
bulins. Except for c~5 for which an homologous sequence has not 
been  identified,  sequences have been grouped  into one of four 
evolutionarily conserved isotypic classes (adapted from Sullivan 
and Cleveland, 1986). Boxed regions delineate peptides chemically 
synthesized  and  used  as  immunogens  for  generating  isotype- 
specific antibodies. 
the appropriate isotype-defining carboxy terminus had been 
successfully generated using the peptide antigens,  we iso- 
lated  cloned  DNA  segments  extending  from  amino  acid 
codon 345 through to the translation termination codon for 
each 13-tubulin isotype. These sequences were inserted into 
the bacterial trpE gene carried i,'l the plasmid pATH 1 such 
that the plasmid encoded a hybrid protein consisting of an 
amino-terminal 32 kD of trpE linked to the carboxy-terminal 
,~10013-tubulin residues. After transformation into an E. coli 
strain (CAG 456) carrying a  mutation in the Ion protease 
gene (Snyder et al.,  1987), expression of the fusion proteins 
was induced with indole acrylic acid. SDS-PAGE of lysates 
of induced cultures (shown in Fig. 2 A) revealed that for fu- 
sion proteins carrying types I, II, III, mammalian IV (repre- 
sented by a fusion containing the human isotype labeled h-IV 
in Fig. 2), or chicken IV (c-IV) carboxy termini, the fusion 
protein had accumulated to '~5 % of bacterial proteins. For 
the last isot-ype, c135, the level of accumulation was consis- 
tently much lower (Fig. 2 A, lane cV), presumably the result 
of instability of this fusion protein in the bacterial host. 
To test the specificities of antisera raised against each pep- 
tide, we electrophoresed our battery of fusion proteins (in- 
cluding both type II and type III variants) on eight parallel 
SDS-polyacrylamide gels. One gel, shown in Fig. 2 A, was 
Figure 2. Specificity of  binding of  affinity-purified,  peptide-derived 
antibodies to each 13-tubulin isotype. (A) Coomassie Blue stain of 
an SDS-polyacrylamide gel of  bacterial lysates containing induced, 
cloned fusion proteins, the amino-terminal region of which is the 
bacterial protein trpE and the carboxy-terminal domains are 13-tu- 
bulin  sequences beginning at  13-tubulin residue  345. Lanes  are 
loaded with: P, induced pATH vector alone; M, molecular mass 
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ted and each was probed with a different antibody. Part Tof 
Fig.  2  B  shows  binding  of a  polyclonal antibody  raised 
against chicken brain tubulin  (Cleveland et al.,  1981) and 
which was expected to react with all isoforms. As is evident, 
that expectation was,  in fact, correct. Because whole sera 
gave higher backgrounds immunoblots (not shown), we first 
affinity-purified each antipeptide antibody using the appro- 
priate  peptide  linked  to  Sepharose  (see  Materials  and 
Methods). Immunoblots with these affinity-purified antibod- 
ies revealed: 
/),pe I.  Type I antibodies reacted strongly only with the 
type I-trpE fusion protein (Fig. 2 B, panel I). However, weak 
cross-reactivity was observed to the c-IV fusion protein. The 
only sequence common to type I and type c-IV that is not 
also common to other isotypes (which are not recognized by 
the antibody), is a single alanine that is the final residue in 
type I and the penultimate residue in type c-IV.  Assuming 
an  antibody binding  site to  consist of approximately five 
residues, we conclude that a major epitope recognized by the 
type I  antisera contains AEEEA and that presence of the 
carboxy-terminal A  is essential for binding (see Fig.  1). 
Type H. Antibodies generated against the rat/mouse type 
II 13-tubulin peptide strongly recognize both the rat/mouse 
fusion protein and the homologous (but not identical;  see 
Fig. 1) chicken/pig type II fusion protein (Fig. 2 B, panel//). 
In addition, weaker binding is found to the chicken c-IV iso- 
form, but not the m-IV isotype. No simple explanation for 
cross-reactivity unique to the c-IV isoform is apparent from 
inspection of the sequences (Fig.  1). 
7)2pc III. The type III antibody reacted uniquely with type 
III isoforms and did not recognize any of the other types (Fig. 
2 B, panel III). Reaction with the human type III isotype was, 
however, much stronger than with the chicken type III. Be- 
cause these two fusion polypeptides differ only in two resi- 
due positions (both within the terminal five amino acids), the 
principal  epitope(s) recognized by the type III antibodies 
must lie within the extreme carboxy-terminal positions. 
Type  IV.  The  peptide-derived  type  m-IV  antibodies 
reacted exclusively with type IV fusions, with strong staining 
of the mammalian type IV fusion protein (labeled h-IV) and 
weaker binding seen to the chicken c-IV isotope. This was 
in contrast to the antibody derived from injection of the c-IV 
peptide  itself.  That antibody reacted exclusively with the 
c-IV fusion protein (Fig. 2 B, panel c-IV). Because, like the 
type In example (above), the only sequence differences be- 
tween the chicken IV and the mammalian IV fusion polypep- 
tides are the final two carboxy-terminal residues, the c-IV 
antibody must exclusively recognize a determinant contain- 
ing these residues. 
c-V. Antibodies to the cl35 peptide (to be referred to hence- 
forth as c-V) reacted exclusively with the c-V fusion protein 
(Fig. 2 B, panel cV). (The binding of  this antibody to a fusion 
polypeptide of the appropriate size confirms the assignment 
of the minor polypeptide in Fig. 2 A, lane cV, as the c-V fu- 
sion protein.) 
Cross-reaction of Type L  II, and IV Antibodies 
Can Be Eliminated by Competition with the 
Cross-reacting Peptide 
Because the goal of  using peptide antigens was to prepare an- 
tibodies that bound solely to individual tubulin isoforms, the 
cross-reaction of  types I and II antibodies to the chicken c-IV 
isotype  was  disappointing.  Although  this  cross-reaction 
would be a significant problem only for analysis of isotype 
utilization  in  the  chicken,  we  reasoned  that  such  cross- 
reaction  might be  eliminated by competition of antibody 
binding in the presence of the excess c-IV peptide. To test 
this,  we incubated parallel blots of cloned fusion proteins 
markers (66, 45, 36, 29, and 22 kD); hL human type I fusion; mlI, 
mouse type II;  clI,  chicken type II; hill,  human type III;  clll, 
chicken type III; hIV, human type IV; c/E, chicken type IV; cV, 
chicken c-V. Arrow points to the position of the type hi fusion pro- 
tein. (B) Autoradiograms of immunoblots of duplicate gels electro- 
phoresed in parallel with that in A. T, general polyclonal antibody 
that recognizes all 13-tubulin isotypes;/, type I antibody; II, type 
II antibody; III, type III antibody; m/E, type m-IV antibody; clV, 
c-IV antibody;  cV,  c-V antibody. All peptide-derived antibodies 
were affinity purified except for anti-type III.  (C) Immunoblots 
done in the presence of the c-IV peptide reduce c-IV cross-reaction 
of the type I, II, and IV antibodies. Autoradiograms of immuno- 
blots of multiple gels electrophoresed in parallel with that in A. For 
each antibody used, antibody binding reaction was identical to that 
in B except that 3 I.tM c-IV peptide was included to compete binding 
to the c-IV fusion protein. L type I peptide antibody; H, type II anti- 
body; mlV, m-IV antibody. 
Figure 3. Quantitative immunoblot assay for detection of  each of six 
I~-tubulin isotypes. The concentrations of accumulated trpE/13-tu- 
bulin fusion proteins in lysates from induced bacteria were deter- 
mined as in Materials and Methods. From those measurements, di- 
lutions of each of the six fusion protein lysates were made to load 
80, 40, 20, 10, and 5 ng of fusion protein on adjacent lanes of SDS- 
polyacrylamide gels and the  resultant gels were immunoblotted 
with the peptide-derived antibodies./, type I antibody; II, type II 
antibody; III, type III antibody; m/E, type m-IV antibody; c/E, type 
c-IV antibody; and cV, type c-V antibody. Panels represent over- 
night exposures except for III and cV which are 4-h exposures. 
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with type I and type II affinity-purified antibodies, but this 
time in the presence of 3 ~tM c-IV peptide. The outcome of 
that experiment is shown in Fig. 2 C. Clearly, the c-IV pep- 
tide had no discernible effect on binding of the specific type 
I or II antibodies, whereas it completely eliminated binding 
of the type I antibody to the c-IV fusion protein and severely 
diminished binding of the type II antibody to c-IV. 
To  test  if peptide  competition  could  eliminate  cross- 
reaction between mammalian type IV and chicken type IV, 
a final blot of  fusion proteins was prot~ with the m-IV anti- 
body, again in the presence of 3 IxM c-IV peptide. The con- 
siderable cross-reactivity seen in the absence of competition 
(Fig. 2 B, panel m/V) was completely eliminated (Fig. 2 C, 
panel m/V). 
A Quantitative BlotAssayfor Each of  Six 
~-Tubulin Isoforms 
By electrophoresing serial dilutions of known amounts of 
cloned fusion protein lysates followed by immunoblotting 
(see Materials and Methods), we determined the sensitivity 
of each of our affinity-purified antibodies for recognition of 
the corresponding isotypes. Examples of those analyses are 
shown in Fig. 3. As might be anticipated, the six antibodies 
have different sensitivities of binding. For example, the type 
III, m-IV, c-IV,  and cV antibodies could easily detect 5 ng 
of fusion protein, whereas the corresponding type I and II 
antibodies were approximately fourfold less sensitive. None- 
theless, for each antibody this protocol allowed a convenient 
method for quantitating levels of polypeptide type in a mix- 
ture of isoforms. 
Using this immunoblot assay followed by densitometry, we 
analyzed the isotype composition of I~-tubulins in 313 cells 
(an established line of  mouse fibroblasts), secondary chicken 
embryo fibroblasts (CEF), and CV1 ceils, a fibroblastic line 
of cells from monkey kidney. The quantitative results of that 
assay are presented in Table I. Types I and IV are the major 
isoforms in all of these fibroblastic cells, although the pro- 
portion of types I and IV are markedly different in each cell 
type. In addition, we found that the 3T3 cells contain an iso- 
type that reacts with the anti-cV antibody (binding of which 
is blocked only by the c-V peptide). This was surprising be- 
cause a gene that encodes such a polypeptide isotype has not 
yet been discovered outside of chicken. From these immuno- 
blot results (in conjunction with immunofluorescent local- 
ization; see below) we conclude that mouse fibroblasts con- 
tain a c135-1ike polypeptide isotype that comprises at least 
20% of the I~ tubulins. 
Figure 4. Specific binding of the anti-m-IV antibody to the m-IV 
isotype in 3"1"3  cell microtubules. Affinity purified, anti-m-IV anti- 
body was used to stain microtubules in 3T3 cells using the technique 
of indirect immunotiuorescence. Specificity of antibody detection 
of  m-IV isotype in microtubules was determined by competing anti- 
body binding by addition of  peptides corresponding to each isotype. 
T, immunofluorescent staining of mouse 313 cells with an anti- 
l~-tubulin monoclonal antibody (Amersharn Corp.); mlV, immuno- 
fluorescent staining of mouse 3T3 cells with the anti-isotype m-IV 
antibody. All other parts were anti-mlV staining but done in the 
presence of 3 l.tM type I (p-l), type II (p-H), type III (p-Ill), 
type m-IV (p-m/V), type c-IV (p-c/V), or type cV (p-cV)  peptides. 
Bars, 10 ~tm. 
The Journal of Cell Biology.  Volume 105, 1987  1712 The Journal of Cell Biology,  Volume  105, 1987  1714 Figure 6. Detection of [3-tubulin isotypes in CEF cell microtubules using indirect immunofluorescence. Isotypes present in CEF cells were 
detected by indirect immunofluorescence using the antipeptide antibodies. 1, antibody to type 113-tubulin; II, antibody to type II; III, anti- 
body to type III; mlV, antibody to type m-IV; clV, antibody to type c-IV; and cV, antibody to type c-V. Lower two sections of/, c/V, and 
cVdisplay mitotic spindles and midbodies stained with the anti-type I, c-IV and c-V antibodies, respectively. All peptide antibodies except 
type III were affinity purified.  Bars,  10 txm. 
The Peptide Antibodies Bind to Specific ~-Tubulin 
Isotypes in Microtubules 
Having  demonstrated  that  the  peptide-derived  antibodies 
bind  specifically  to  the  corresponding  isotypes  on  protein 
blots, we next determined whether the antibodies could also 
react  with  the  appropriate  isotypes  when  assembled  into 
microtubules.  To do this, we first stained 3T3 cells with the 
anti-m-IV antibody  corresponding  to an isotype known to 
represent >50%  of cell  13 tubulins  (see Table I). Antibody 
binding  was observed by indirect  immunofluorescence.  As 
shown in Fig.  4,  panel mlV, interphase  microtubule  arrays 
showed extensive staining by the anti-m-IV antibodies.  (In- 
Figure 5. Detection of ~-tubulin isotypes in mouse 313 cell microtubules using indirect immunofluorescence. Isotypes present in 313 cell 
microtubules were detected by indirect immunofluorescence using the antipeptide antibodies. T, polyclonal antibody raised against chicken 
brain tubulin;  I, antibody specific to type I; II, antibody to type II; III, antibody to type III; mlV, antibody to type m-IV; clV, antibody 
to type c-IV; and cV; antibody to type c-V. Middle section of I, m/E, and cV display staining patterns when antibody binding is done in 
the presence of the 3 txM type I, type m-IV or type c-V peptides, respectively. Bottom two sections of T, I, m/l~, and cV display mitotic 
spindle and midbody staining,  respectively. All peptide antibodies except type III were affinity  purified.  Bars,  10 ~tm. 
Lopata and Cleveland Antibodies Specific to Six ~-Tubulin lsotypes  1715 Figure 7. Detection of 13-tubulin isotypes in CV1 cell microtubules using indirect immunofluorescence. Isotypes present in CV1 ceils were 
detected by indirect immunofluorescence using the antipeptide antibodies. I, antibody to type I ~-tubulin; H, antibody to type II; III, anti- 
body to type III; role antibody to type m-IV; clV, antibody to type c-IV; and cV, antibody to type c-V. Lower two sections of / and mll/ 
display staining of a mitotic spindle and a midbody with the anti-type I and type m-IV antibodies, respectively. All peptide antibodies 
except type III were affinity purified. Bars, 10 lam. 
deed, qualitatively the pattern of staining was indistinguish- 
able from that seen with a  13-tubulin monoclonal antibody 
[Fig. 4, panel T].) To test whether such binding represented 
specific binding to the appropriate isotype, we repeated the 
staining procedure on parallel aliquots of cells but this time 
added to each antibody binding mixture 3 I~M of one of the 
various peptides. As seen in Fig. 4, panel m-IV/p-mlE addi- 
tion of the type m-IV peptide to the type m-IV antibody com- 
pletely blocked microtubule staining,  whereas addition of 
any of the peptides for the other isotypes left staining un- 
diminished (panels p-I through p-cV). 
Analogous blocking experiments for each of the other anti- 
isotype antibodies revealed that staining was always blocked 
only by addition of the correct peptide (see below). 
The Journal of Cell Biology, Volume  105,  1987  1716 Figure 8.  Quantitative analysis of soluble and polymer levels of 
each [3-tubulin  isotype in CEF, 3T3, and CV1 cells. Soluble tubulin 
and polymeric tubulin were prepared from dishes of CEF, 313, and 
CV1 ceils (as detailed in Materials and Methods). Equivalent frac- 
tions of soluble and polymeric samples were electrophoresed  on six 
gels (40 ~tg of total cell protein was analyzed, ~,50  % of which was 
in the polymeric fraction). (A) Soluble and polymeric fractions as 
visualized by Coomassie  Blue staining. The two lanes at the left dis- 
play purified brain tubulin and molecular mass standards (205, 116, 
97, 66, 45, and 29 kD), respectively. (B) To quantify the amounts 
of each isotype in each sample, serial dilutions of a bacterial lysate 
containing a  specific trpE-13-tubulin fusion  protein were also 
loaded on parallel gels. The gels were blotted and incubated with 
We  conclude  that  the  antibodies  retain  their  isotype- 
specificity when binding to intact microtubules. 
In Vivo Colocalization of  lsotypes I, IV,, and c-V 
in Interphase, Mitotic, and Midbody Microtubules 
We next sought to determine which 13-tubulin isotypes were 
assembled in the various classes of  microtubules distinguish- 
able within an animal cell by light microscopy. For this, we 
stained microtubules in each of three different cultured cells 
(3T3, CEE and CV1  cells). 
The staining of 313 cells with each of the six isotype anti- 
bodies is shown in Fig. 5. As expected from the protein blot- 
ring experiment (Table I), antibodies to isotypes I, m-IV, and 
c-V stained microtubules (parts L  m/E, and cV),  as did a 
tubulin polyclonal antibody (part T) that recognizes all iso- 
types (see Fig. 2 A). No microtubule staining was observable 
for isotypes H, III, and c-IV.  (For each peptide antibody, 
microtubule staining is specific to the appropriate isotype in- 
asmuch as binding is completely blocked by addition of the 
corresponding peptide [see middle section of panels I, m/K, 
and cg].) Moreover, what is readily apparent is that each iso- 
type is present in an apparently uniform distribution in all 
classes of microtubules (interphase, spindle, and midbody). 
Analysis of microtubules in CEF and CV1 cells yielded 
results qualitatively similar to those from the 3T3s. All iso- 
types demonstrated to be present by immunoblot analysis 
(types I, c-IV, and c-V in CEFs and types I and IV in CVls) 
were present in interphase, mitotic, and midbody microtu- 
bules (Fig. 6 and 7). Moreover, except for the possibility that 
in CEF cells astral microtubules may be enriched in the type 
I tubulin (see Fig. 6, panel I), no preferential utilization of 
any isotype was apparent for any microtubule class. (We be- 
lieve that the stronger staining of astral fibers by anti-type 
I antibody reflects the large percentage of type I 13-tubulin 
present [see Table I] and that the mitotic cell in Fig. 6, panel 
I represents a cell earlier in the cell cycle than those in Fig. 
6, panels c/V and cV.) 
That each antibody stains the entire repertoire of microtu- 
bules is  further supported by double-immunofluorescence 
experiments. For such experiments, each peptide antibody 
was used simultaneously with a 13-tubulin monoclonal anti- 
body. No microtubules could be identified that were detected 
by the monoclonal but failed to stain with an isotype specific 
antibody (data not shown). 
Quantitative Analysis of  ~-Tubulin Isotypes in Cultured 
Animal Cells: Similar Interphase Monomer/Polymer 
Ratios for Each Isotype 
To determine whether an isotype (or isotypes) was preferen- 
tially utilized for microtubule assembly, the identities and 
the appropriate antipeptide antibodies. Antibody binding was de- 
tected with ~25I-protein A. P, polymeric tubulin; M, monomeric 
(soluble) tubulin; L anti-type I-specific antibody; II, anti-type II- 
specific  antibody;  III,  anti-type  HI-specific  antibody;  mIV, 
anti-type m-IV-specific  antibody; c/E anti-type c-IV antibody; cV, 
anti-type c-V antibody; T, monoclonal antibody that reacts with all 
isotypes. The first three lanes of II, IIl,  mlE, cll~, and cV were 
loaded with 200, 60, and 20 ng of the corresponding cloned fusion 
protein. ('l'~pe III fusion protein was the human protein.) For L fu- 
sion protein amounts  were 600, 200, and 60 ng. All peptide antibod- 
ies except type III were affinity purified. 
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meric form in a variety of cultured animal cells were deter- 
mined by quantitative immunoblotting. By gently lysing ali- 
quots of cells under conditions that stabilize microtubules 
(Solomon et al.,  1979; Osborn and Weber,  1982), we first 
fractionated cellular proteins into soluble and cytoskeletal 
fractions. Equivalent proportions of each fraction were elec- 
trophoresed along with appropriate levels of cloned fusion 
proteins corresponding to each ~ tubulin isotype. A gel of 
soluble and polymer fractions stained with Coomassie Blue 
is shown in Fig. 8 A. Immunoblots of gels run in parallel are 
shown in Fig. 8 B and the amount of each isotype in soluble 
and polymer forms is quantified in Table I. In all three cell 
types, just over 50% of cell tubulin is in the polymeric form 
(in agreement with measurements for fibroblasts by previous 
investigators [e.g.,  Hiller and Weber,  1978; Caron et al., 
1985]). Moreover, a similar level of each isotype present is 
in the  assembled form, although quantitatively a  slightly 
lower (but reproducible) percentage of isotype c-V was as- 
sembled in both CEF and 3T3 cells. 
Discussion 
The preparation of antibodies that recognize specific 13-tubu- 
lin isotypes has permitted both quantitation of the amount of 
each isoform in the soluble and polymer forms and direct 
localization of each  by  indirect immunofluorescence mi- 
croscopy. Several important observations emerge from such 
analyses. 
First, the finding that each antibody appears to stain the 
entire repertoire of microtubules provides strong evidence 
that most, if not all, cellular microtubules are assembled as 
copolymers of available isotypes. This appears to be true for 
microtubules that comprise the interphase cytoplasmic array, 
for mitotic microtubules, and for microtubules within the 
midbody. This hypothesis is further supported by double- 
immunofluorescence experiments (not shown). Although it 
remains possible that a small fraction of microtubules may 
be  composed exclusively or preferentially of a  subset of 
available isotypes, it is nonetheless clear that in the examples 
examined thus far the majority of in vivo microtubules are 
copolymers of isotypes. 
Secondly, not only are microtubules of divergent cellular 
functions composed largely (if not exclusively) of copoly- 
mers of various isotypes, we have been unable to detect any 
preferential utilization of  any particular isoform in any subset 
of microtubules. Although the limited resolution of light mi- 
croscopy may obscure subtle biases for incorporation of an 
isotype into some microtubule subset, no enrichment of any 
isotype is apparent in any microtubule class. Neither can any 
marked preferential utilization be detected by the proportion 
of each isoform that is assembled into polymer (although a 
slightly lower level of assembly of the c-V isotype was de- 
tected). 
Thirdly, although we have previously noted the marked 
evolutionary conservation of the primary sequences and pat- 
terns of expression of each of four I~-tubulin isotypic classes 
(Sullivan  and  Cleveland,  1986),  our  present  quantitative 
analysis of isotypes present in chicken, mouse, and monkey 
fibroblasts show markedly different levels of isotypes (Table 
I). Although this may in part reflect differences between the 
established 313 line and the secondary CEFs, this observa- 
tion is nonetheless difficult to reconcile fully with the notion 
that tubulin isotypes confer novel functional properties to the 
assembled  microtubule.  If  tubulin  isotypes  contributed 
unique, albeit subtle, functional properties to microtubules, 
how is it that very different levels of  each isoform are permis- 
sible in similar cell types from different species? 
In conjunction with a similar analysis from Cowan's group 
that employed isotype-specific antisera and gene transfection 
(published while this manuscript was under review [Lewis 
et al.,  1987]) and with the companion paper (Joshi  et al., 
1987)  in  which  we  demonstrate  that  the  very  divergent 
chicken erythrocyte 13-tubulin (cl36) (which is normally as- 
sembled into marginal band microtubules in red blood cells) 
freely coassembles with other isotypes both in its normal 
erythrocyte environment and when expressed inappropri- 
ately in other cell types, these observations further support 
a variety of preceding genetic and biochemical evidence that 
multiple tubulin isotypes do not contribute to specifying es- 
sential functional distinctions among microtubule classes. 
The earliest (and in many ways most compelling) prior evi- 
dence came from Raft and co-workers (Kemphues et al., 
1982),  who demonstrated in Drosophila that all microtu- 
bules in developing spermatids (including microtubules in- 
volved in mitosis, meiosis, flagella assembly, and nuclear 
shaping) were all composed principally of a  single mul- 
tifunctional I~-tubulin isotype. This work was followed by 
two divergent experiments from Solomon and co-workers 
that cast additional doubt as to the functional divergence of 
tubulin isotypes. These efforts included demonstration that 
an unusual hybrid 13-tubulin (composed of a chicken amino 
terminus linked to a yeast carboxy terminus) coassembled 
into all classes of 313 cell microtubules that are distinguish- 
able by light microscopy (Bond et al., 1986). In addition, in 
vitro  reassembly  experiments  showed  that  the  divergent 
erythrocyte 13-tubulin (cl36) could be replaced by brain tubu- 
lin subunits in marginal band microtubules (Swan and Solo- 
mon,  1984). 
On  the other hand,  we (Sullivan and Cleveland,  1986; 
Cleveland, 1987) and others (Villasante et al., 1986) have ar- 
gued that the interspecies conservation of isotypic sequences 
and programs of expression of each isotype support func- 
tional differences among isotypes. Further, direct in vitro 
biochemical evidence has demonstrated marked differences 
in assembly properties of brain tubulins and the erythrocyte 
cl36 tubulin (Rothwell et al., 1986). Indeed, we have shown 
in a forthcoming article (Joshi et al., 1987) that the c1~6 iso- 
type is preferentially assembled into more stable erythrocyte 
microtubules. In addition, proteolytic removal of the isotype 
defining carboxy-terminal domain sequences yields subunits 
that are still competent to assemble in vitro, but with altered 
properties (Brattacharyya et al., 1985; Sackett et al.,  1985; 
Serrano et al., 1984a, b). When coupled with evidence that 
the carboxy-terminal domain may be directly involved in 
binding some microtubule-associated proteins (Serrano et 
al., 1984b), these results suggest that tubulin assembly char- 
acteristics may be modulated in vivo by preferential binding 
of individual microtubule-associated proteins to particular 
isotypes. 
How can these paradoxical findings be reconciled? Three 
possibilities seem most reasonable. First, the comingling of 
various isotypes may not be universal and in vivo examples 
of isotype segregation may yet emerge. Secondly, the coas- 
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that individual subunits may still provide preferential (or ex- 
clusive) binding sites for specialized microtubule-associated 
proteins. In this view, divergent functional characteristics of 
specialized  microtubules  would  thus  be  established  in- 
directly  through associated protein binding to specific  iso- 
types.  Thirdly, despite some altered in vitro properties and 
evolutionary conservation of various isotypes, there may be 
no functional difference in vivo between some (or all) of the 
tubulins.  The conservation in sequence  may simply reflect 
slow ticking of the evolutionary clock since the time of gene 
duplication. 
In any event, if significant differences among tubulin iso- 
types do exist, they must be subtle and manifest only in con- 
junction  with other specific  microtubule components. 
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